03166nam 2200937z- 450 991036775190332120231214133455.03-03921-677-5(CKB)4100000010106198(oapen)https://directory.doabooks.org/handle/20.500.12854/54599(EXLCZ)99410000001010619820202102d2019 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNew Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future ChallengesMDPI - Multidisciplinary Digital Publishing Institute20191 electronic resource (116 p.)3-03921-676-7 This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseasesapolipoproteinlipidsrisk stratificationproprotein convertase subtilisin-kexin type 9 (PCSK9)vaspinsphingolipidsPCSK9ceramidesatrial fibrillationcircular RNASTEMIcholesterollipoproteinscardiovascular disease (CVD)coronary artery bypass graftingatherosclerosisstatinLDL subfractionsacute kidney injurydyslipidemiagene expressionNSTEMINAFLDhyperlipidemianonstatincholesteryl ester transfer proteinlow-density lipoprotein cholesterolanacetrapibHDLacute coronary syndromemiRNAcardiovascular riskpleiotropic actionsgeneticABCA1sdLDLcardiovascular diseaseproprotein convertase subtilisin/kexin type 9inclisiranreverse cholesterol transportsterolsmall interfering RNA (siRNA)RNA-binding proteinscardiovascular diseasesNASHlow-density lipoprotein-cholesterol (LDL-C)strokenutrigeneticstype 2 diabetesstatinssphingomyelinhepatic fibrosisdiabetesBakillah Ahmedauth1287692BOOK9910367751903321New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges3020303UNINA